Fri, Apr 19, 2024
Volume 11, Issue 2 (4-2023)
J. Pediatr. Rev 2023, 11(2): 117-124 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nickavar A, Valavi E, Sadigh N. Urine Neutrophil Gelatinase Associated Lipocalin as a Predictor of Vesicoureteral Reflux and Renal Parenchymal Damage: A Systematic Review. J. Pediatr. Rev 2023; 11 (2) :117-124
URL: http://jpr.mazums.ac.ir/article-1-514-en.html
URL: http://jpr.mazums.ac.ir/article-1-514-en.html
1- Department of Pediatric Nephrology, School of Medicine, Aliasghar Children’s Hospital, Iran University of Medical Sciences, Tehran, Iran.
2- Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3- Department of Emergency, School of Medicine, Aliasghar Children’s Hospital, Iran University of Medical Sciences, Tehran, Iran. , n.sadigh@yahoo.com
2- Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3- Department of Emergency, School of Medicine, Aliasghar Children’s Hospital, Iran University of Medical Sciences, Tehran, Iran. , n.sadigh@yahoo.com
Abstract: (907 Views)
Background: Vesicoureteral reflux (VUR) is the most common congenital urinary tract abnormality in children. Renal parenchymal damage is the most devastating complication of severe undiagnosed VUR. Different diagnostic biomarkers have been introduced as alternatives for radiologic evaluation in these patients. This review article aimed to increase the knowledge about the role of urine neutrophil gelatinase-associated lipocalin (uNGAL) in children affected by primary VUR and renal parenchymal damage.
Methods: A systematic review of PubMed, Scopus, Web of Science, ProQuest, and Ovid was conducted in September 2022 to retrieve studies that investigated the correlation between uNGAL or uNGAL/Cr excretion and primary VUR in male/female patients younger than 18 years of age. Patients with secondary VUR, age older than 18 years, infectious or inflammatory disorders, obstructive uropathies, and acute or chronic kidney diseases were excluded. Two reviewers independently screened the titles and abstracts of the search results and then assessed the full texts selected from the pertinent studies.
Results: Eighteen research articles with a total sample of 699 patients were found to measure uNGAL in VUR or renal scarring. UNGAL or uNGAL/Cr had increased excretion in the majority of children with primary VUR or RPD, with a positive or no correlation to the severity of VUR.
Conclusions: Several studies addressed uNGAL and uNGAL/Cr as putative biomarkers for the prediction of VUR or reflux-associated RPD.
Methods: A systematic review of PubMed, Scopus, Web of Science, ProQuest, and Ovid was conducted in September 2022 to retrieve studies that investigated the correlation between uNGAL or uNGAL/Cr excretion and primary VUR in male/female patients younger than 18 years of age. Patients with secondary VUR, age older than 18 years, infectious or inflammatory disorders, obstructive uropathies, and acute or chronic kidney diseases were excluded. Two reviewers independently screened the titles and abstracts of the search results and then assessed the full texts selected from the pertinent studies.
Results: Eighteen research articles with a total sample of 699 patients were found to measure uNGAL in VUR or renal scarring. UNGAL or uNGAL/Cr had increased excretion in the majority of children with primary VUR or RPD, with a positive or no correlation to the severity of VUR.
Conclusions: Several studies addressed uNGAL and uNGAL/Cr as putative biomarkers for the prediction of VUR or reflux-associated RPD.
Keywords: Vesicoureteral reflux, VUR, Urinary tract infections, UTI, Renal parenchymal damage, Renal scar, Renal scarring
Type of Study: Review Article |
Subject:
Urology
Received: 2022/12/4 | Accepted: 2023/03/11 | Published: 2023/04/1
Received: 2022/12/4 | Accepted: 2023/03/11 | Published: 2023/04/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Mazandaran University of Medical Sciences.
Published by Negah Institute for Scientific Communication.
Journal of Pediatrics Review (JPR)
Bou Ali Sina Hospital, Pasdaran Boulevard, Sari, Iran.
Journal Tel: +98 - 1133342331
Publisher Tel: +9821 8603 6497-
+9821 8603 7228 (EXT: 104)
Website: http://jpr.mazums.ac.ir/
E-mail: jpr.mazums@gmail.com,
jpr@mazums.ac.ir
